Every GLP-1 Price Drop Since November 2025, on One Page
⚡ Key Takeaways
- Oral Wegovy launched at $149/month in December 2025 — cheapest brand-name GLP-1 ever
- Medicare BALANCE Bridge at ~$50/month starts July 1, 2026
- IRA negotiated Ozempic at ~$274/month takes effect January 2027
- Compounded semaglutide now starts at $119/month — down from $300+ two years ago
- Every major pricing event since Nov 2025 has pushed prices lower — the trend continues
Table of Contents
The Complete Price Drop Timeline
GLP-1 pricing has moved faster in the last 18 months than in the previous five years combined. Here's every significant price event, in chronological order, and what each one means for your wallet.
October 2024
Tirzepatide shortage resolved
FDA removes tirzepatide from shortage list. Compounding pathway begins to narrow for Mounjaro/Zepbound.
November 2025
Novo Nordisk slashes self-pay to $349/mo
NovoCare launches $349/month Wegovy self-pay program. First time brand-name semaglutide drops below $400 for consumers.
December 2025
Oral Wegovy approved — $149/mo starting dose
FDA approves oral semaglutide for weight loss. NovoCare prices it at $149/mo (starting doses) — the cheapest brand-name GLP-1 ever.
December 2025
CMS announces BALANCE Model
Medicare Part D GLP-1 coverage program announced. Bridge starts July 2026 at ~$50/month. Full Part D coverage targeted for January 2027.
February 2025
Semaglutide shortage resolved
FDA removes semaglutide from shortage list. Compounding landscape shifts to non-copy formulations only.
March 2026
FDA issues 30 warning letters to compounders
Crackdown on misleading marketing. Compliant compounders continue operating under 503A/503B pathways.
April 1, 2026
FDA clarifies compounding rules
Formal policy: no exact copies of commercially available products. Non-copy formulations remain legal.
July 1, 2026 — UPCOMING
Medicare BALANCE Bridge launches
Medicare Part D patients gain GLP-1 access at ~$50/month copay through participating plans.
Late 2026 — UPCOMING
Novo Nordisk next-gen weekly injection
New, more effective weekly semaglutide injection expected to reach market. Pricing TBD.
January 2027 — UPCOMING
IRA negotiated Ozempic price: ~$274/mo
Inflation Reduction Act's negotiated Medicare price takes effect. Sets new pricing benchmark industry-wide.
The trend is unmistakable: every major pricing event in the last 18 months has moved prices DOWN. Brand manufacturers are competing with compounders. Medicare is entering the market. Generics are on the horizon internationally. If you've been waiting for a cheaper GLP-1, the wait is over.
Today's Lowest Prices
Here's where to find the best GLP-1 deals right now, accounting for all the price drops above:
Current Lowest Prices — Updated April 2026
| Provider | Starting Price | |
|---|---|---|
| Get Thin MD | $119/mo | Check Price → |
| Yucca Health | $149/mo | Check Price → |
| Care Bare Rx | $169/mo | Check Price → |
| Novi | $174/mo | Check Price → |
| Sesame Care | from $199 | Check Price → |
| Synergy Rx | $199/mo | Check Price → |
Paid links · Compounded medications are not FDA-approved. Verify pricing on provider's site.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Prices are estimates based on publicly available information as of April 2026 and may not reflect current costs. Always verify pricing directly with providers. Compounded medications are NOT FDA-approved. Consult a healthcare provider before starting any medication.
Affiliate Disclosure: GLP-1 Pricelist may earn commissions from provider links. This does not influence our price reporting or recommendations. Full disclosure →